OSI Pharmaceuticals M&A Summary
OSI Pharmaceuticals has acquired 3 companies of its own. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
OSI Pharmaceuticals’ largest acquisition to date was in 2005, when it acquired Eyetech Pharmaceuticals for $935M. It’s largest disclosed sale occurred in 2012, when it sold Eyetech Pharmaceuticals to Bausch Health Companies for $22M. OSI Pharmaceuticals has acquired in 3 different US states. The Company’s most targeted sectors include life science (100%).
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity3
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 3
Unlimited Searches
